Positive sentinel lymph node biopsy predicts local metastases during the course of disease in Merkel cell carcinoma

References

• Heath M, Jaimes N, Lemos B, Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375–81.
   PubMed Web of Science ®Google Scholar
• Allen PJ, Bowne WB, Jaques DP, Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300–9.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC. editors. Merkel cell carcinoma. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p. 315–23.
   Google Scholar
• Lemos BD, Storer BE, Iyer JG, Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751–61.
   PubMed Web of Science ®Google Scholar
• Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003;49:832–41.
   PubMed Web of Science ®Google Scholar
• Albores-Saavedra J, Batich K, Chable-Montero F, Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010;37:20–7.
   PubMed Web of Science ®Google Scholar
• Stokes JB, Graw KS, Dengel LT, Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol 2009;27:3772–7.
   PubMed Web of Science ®Google Scholar
• Bichakjian CK, Lowe L, Lao CD, Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007;110:1–12.
   PubMedGoogle Scholar
• Gupta SG, Wang LC, Penas PF, Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685–90.
   PubMedGoogle Scholar
• Smith DE, Bielamowicz S, Kagan AR, Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 cases. Am J Clin Oncol 1995;18:199–203.
   PubMedGoogle Scholar
• Eng TY, Boersma MG, Fuller CD, A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol 2007;30:624–36.
   Google Scholar
• Mehrany K, Otley CC, Weenig RH, A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113–17.
   PubMed Web of Science ®Google Scholar
• Schwartz JL, Griffith KA, Lowe L, Features predicting sentinel lymph node positivity in merkel cell carcinoma. J Clin Oncol 2011;29:1036–41.
   PubMedGoogle Scholar
• Fields RC, Busam KJ, Chou JF, Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011;18:2529–37.
   PubMed Web of Science ®Google Scholar
• Gommans GM, Gommans E, van der Zant FM, 99mTc Nanocoll: a radiopharmaceutical for sentinel node localisation in breast cancer - in vitro and in vivo results. Appl Radiat Isot 2009;67:1550–8.
   PubMed Web of Science ®Google Scholar
• Maza S, Trefzer U, Hofmann M, Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging 2006;33:433–40.
   PubMed Web of Science ®Google Scholar
• Schmalbach CE, Lowe L, Teknos TN, Reliability of sentinel lymph node biopsy for regional staging of head and neck merkel cell carcinoma. Arch Otolaryngol Head Neck Surg 2005;131:610–14.
   PubMedGoogle Scholar
• Tai P, Yu E, Assouline A, Management of Merkel cell carcinoma with emphasis on small primary tumors - a case series and review of the current literature. J Drugs Dermatol 2010;9:105–10.
   Google Scholar
• Poulsen M, Round C, Keller J, Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb - a review of 60 cases. Int J Radiat Oncol Biol Phys 2010;76:393–7.
   Google Scholar
• Guler-Nizam E, Leiter U, Metzler G, Clinical course and prognostic factors of Merkel cell carcinoma of the skin. Br J Dermatol 2009;161:90–4.
   Google Scholar
• Liebau J, Arens A, Schwipper V, Schulz A. Sentinel lymph node mapping for patients with Merkel cell carcinoma - experience of 5 years. Eur J Plast Surg 2006;29:107–9.
   Google Scholar
• Koljonen V, Suominen S. Sentinel node biopsy in local anaesthesia in patients with head and neck Merkel cell carcinoma. Eur J Plast Surg 2008;30:205–10.
   Google Scholar
• Testori A, De Salvo GL, Montesco MC, Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 2009;16:2018–27.
   Google Scholar
• van der Ploeg IM, Nieweg OE, van Rijk MC, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008;34:1277–84.
   PubMed Web of Science ®Google Scholar
• Bajetta E, Celio L, Platania M, Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol 2009;16:2985–93.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, editors. Merkel cell carcinoma. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p 315–23.
   Google Scholar